ORL. Endoscopie du sommeil induit par les médicaments (DISE): indications et bénéfices [ORL. Drug induced sleep endoscopy (DISE): indications and benefits]

Fiche du document

Date

17 janvier 2024

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2024.20.856-7.88

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/38231108

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_882713E0E91D8

Licences

info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2025-07-17 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/


Résumé 0

Obstructive sleep apnea (OSA) is a common condition that can cause daytime or nocturnal symptoms with long-term impact on the patient's health. Various therapies and surgeries have been introduced over the years, and patient wishes and compliance are essential factors in the success of treatment. Drug-induced sleep endoscopy (DISE) is a procedure that assesses the opening and closing of the upper airway in real time. This article summarizes the indications and contraindications of DISE, with a review of sedation methods and the VOTE classification system, in order to facilitate the use of a common nomenclature based on a protocol applied at the CHUV.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets